GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulse Biosciences Inc (NAS:PLSE) » Definitions » Shiller PE Ratio

PLSE (Pulse Biosciences) Shiller PE Ratio : (As of Apr. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Pulse Biosciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pulse Biosciences Shiller PE Ratio Historical Data

The historical data trend for Pulse Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulse Biosciences Shiller PE Ratio Chart

Pulse Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pulse Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pulse Biosciences's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulse Biosciences's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pulse Biosciences's Shiller PE Ratio falls into.


;
;

Pulse Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pulse Biosciences's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Pulse Biosciences's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.31/133.1571*133.1571
=-0.310

Current CPI (Dec. 2024) = 133.1571.

Pulse Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.058 99.621 -0.078
201506 -0.078 100.684 -0.103
201509 -0.098 100.392 -0.130
201512 -0.132 99.792 -0.176
201603 -0.132 100.470 -0.175
201606 -0.226 101.688 -0.296
201609 -0.206 101.861 -0.269
201612 -0.206 101.863 -0.269
201703 -0.226 102.862 -0.293
201706 -0.423 103.349 -0.545
201709 -0.511 104.136 -0.653
201712 -0.521 104.011 -0.667
201803 -0.501 105.290 -0.634
201806 -0.531 106.317 -0.665
201809 -0.629 106.507 -0.786
201812 -0.501 105.998 -0.629
201903 -0.482 107.251 -0.598
201906 -0.541 108.070 -0.667
201909 -0.560 108.329 -0.688
201912 -0.649 108.420 -0.797
202003 -0.560 108.902 -0.685
202006 -0.521 108.767 -0.638
202009 -0.501 109.815 -0.607
202012 -0.531 109.897 -0.643
202103 -0.698 111.754 -0.832
202106 -0.570 114.631 -0.662
202109 -0.472 115.734 -0.543
202112 -0.511 117.630 -0.578
202203 -0.570 121.301 -0.626
202206 -0.433 125.017 -0.461
202209 -0.482 125.227 -0.513
202212 -0.246 125.222 -0.262
202303 -0.256 127.348 -0.268
202306 -0.220 128.729 -0.228
202309 -0.190 129.860 -0.195
202312 -0.210 129.419 -0.216
202403 -0.177 131.776 -0.179
202406 -0.200 132.554 -0.201
202409 -0.210 133.029 -0.210
202412 -0.310 133.157 -0.310

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pulse Biosciences  (NAS:PLSE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pulse Biosciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pulse Biosciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulse Biosciences Business Description

Traded in Other Exchanges
Address
601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Executives
Robert W Duggan director, 10 percent owner 611 SOUTH FORT HARRISON AVE, SUITE 306, CLEARWATER FL 33756
Kevin Patrick Danahy officer: Chief Commercial Officer 50 TEABERRY LANE, BRAINTREE MA 02184
Mitchell E. Levinson director 3957 POINT EDEN WAY, HAYWARD CA 94545
Manmeet Singh Soni director C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVE, SUNNYVALE CA 94085
Van Den Broek Richard director 73 ARCH STREET, 1ST FLOOR, GREENWICH CT 06830
Maky Zanganeh director 51 ADAM WAY, ATHERTON CA 94027
Sandra A. Gardiner officer: CFO & EVP Admin. and Finance CUTERA, INC., 3240 BAYSHORE BOULEVARD, BRISBANE CA 94005
Shelley D Spray director C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD CA 94545
Laureen Debuono director
Ed Ebbers officer: EVP & GM, Dermatology 3957 POINT EDEN WAY, HAYWARD CA 94545
Kenneth A Clark director C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVE., SUNNYVALE CA 94085
Fogarty Thomas J M D director C/O VENTURE LAW GROUP, 2800 SAND HILL RD STE 270, MENLO PARK CA 94025
Thierry B. Thaure director 3957 POINT EDEN WAY, HAYWARD CA 94545
Robert J. Greenberg director 12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR CA 91342
Brian B Dow officer: CFO & SVP Admin. and Finance 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588